141 related articles for article (PubMed ID: 8618811)
1. [Influence of long-term treatment with human recombinant erythropoietin on secretion of hormones regulating carbohydrate metabolism in hemodialyzed patients with chronic uremia].
Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
Pol Arch Med Wewn; 1995 Dec; 94(6):488-94. PubMed ID: 8618811
[TBL] [Abstract][Full Text] [Related]
2. Influence of long-term erythropoietin treatment on insulin, glucagon, pancreatic polypeptide, and gastrin secretion in haemodialysed patients.
Kokot F; Nieszporek T; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
Nephrol Dial Transplant; 1994; 9 Suppl 3():35-9. PubMed ID: 8072722
[TBL] [Abstract][Full Text] [Related]
3. [Influence of long-term human recombinant erythropoietin treatment on secretion of pancreatic polypeptide and gastrin in hemodialysed patients with chronic renal failure].
Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
Przegl Lek; 1995; 52(12):590-3. PubMed ID: 8834657
[TBL] [Abstract][Full Text] [Related]
4. Influence of long-term erythropoietin therapy on endocrine abnormalities in haemodialyzed patients.
Kokot F; Wiecek A; Schmidt-Gayk H; Marcinkowski W; Nieszporek T; Rudka R; Trembecki J
Przegl Lek; 1992; 49(1-2):43-9. PubMed ID: 1455006
[TBL] [Abstract][Full Text] [Related]
5. [Influence of long-term erythropoietin (rHuEPO) therapy on the function of the pituitary-gonadal axis in hemodialyzed male patients with end stage renal failure].
Trembecki J; Kokot F; Wiecek A; Marcinkowski W; Rudka R
Pol Arch Med Wewn; 1995 Aug; 94(2):144-52. PubMed ID: 8596749
[TBL] [Abstract][Full Text] [Related]
6. [Does long-term human recombinant erythropoietin (rHuEPO) influence secretion of hormones regulating volume and pressure of arterial blood?].
Rudka R; Kokot F; Wiecek A; Marcinkowski W; Trembecki J
Pol Arch Med Wewn; 1994 Aug; 92(2):154-61. PubMed ID: 7800584
[TBL] [Abstract][Full Text] [Related]
7. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
[TBL] [Abstract][Full Text] [Related]
8. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
[TBL] [Abstract][Full Text] [Related]
10. [The effect of recombinant human erythropoietin (rHu-EPO) on the autonomic nervous system in patients hemodialyzed for chronic kidney failure].
Pacyk G; Grzeszczak W
Pol Arch Med Wewn; 1997 Jan; 97(1):22-9. PubMed ID: 9235548
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.
Albertazzi A; Di Liberato L; Daniele F; Battistel V; Colombi L
Int J Artif Organs; 1998 Jan; 21(1):12-8. PubMed ID: 9554820
[TBL] [Abstract][Full Text] [Related]
12. Influence of long-term recombinant human erythropoietin (rHuEpo) therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients.
Kokot F; Wiecek A; Mesjasz J; Adamczak M; Spiechowicz U
Nephrol Dial Transplant; 1998 May; 13(5):1200-5. PubMed ID: 9623554
[TBL] [Abstract][Full Text] [Related]
13. [The effect of recombinant erythropoietin on candidicidal activity of polymorphonuclear leukocytes in hemodialyzed patients].
Bartůnková J; Sulková S; Cebecauer M
Cas Lek Cesk; 1995 Dec; 134(23):756-9. PubMed ID: 8599817
[TBL] [Abstract][Full Text] [Related]
14. [The effect of hemodialysis on levels of beta-endorphin in serum of patients with chronic renal failure treated with erythropoietin].
Burak W; Grzeszczak W; Trelewicz P; Zukowska-Szczechowska E
Przegl Lek; 1996; 53(2):54-7. PubMed ID: 8754321
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-alpha-D3.
Stefanovic V; Djordjevic V; Ivic M; Mitic-Zlatkovic M; Vlahovic P
Ann Clin Biochem; 2005 Jan; 42(Pt 1):55-60. PubMed ID: 15802034
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
[TBL] [Abstract][Full Text] [Related]
17. Functional erythropoietin-hepcidin axis in recombinant human erythropoietin independent haemodialysis patients.
Touzot M; Lefebvre T; Roux A; Maheas C; Ridel C; Puy H; Karim Z
Nephrology (Carlton); 2019 Jul; 24(7):751-757. PubMed ID: 30175513
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Khan I; Rabindranath K; Vale L; Wallace S; Macleod A
Cochrane Database Syst Rev; 2005 Jul; (3):CD003266. PubMed ID: 16034896
[TBL] [Abstract][Full Text] [Related]
19. [Improvement of sexual function in hemodialyzed male patients with chronic renal failure treated with erythropoietin (rHuEPO)].
Trembecki J; Kokot F; Wiecek A; Marcinkowski W; Rudka R
Przegl Lek; 1995; 52(9):462-6. PubMed ID: 8834648
[TBL] [Abstract][Full Text] [Related]
20. Effect of short-term rHuEPO treatment on insulin resistance in haemodialysis patients.
Spaia S; Pangalos M; Askepidis N; Pazarloglou M; Mavropoulou E; Theodoridis S; Dimitrakopoulos K; Milionis A; Vayonas G
Nephron; 2000 Apr; 84(4):320-5. PubMed ID: 10754408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
